Lyn-deficient mice develop severe, persistent asthma: Lyn is a critical negative regulator of Th2 immunity

Sarah Jane E. Beavitt, Kenneth W. Harder, Joanna M. Kemp, Jessica Jones, Cathy Quilici, Franca Casagranda, Ellen Lam, Debra Turner, Siobhain Brennan, Peter D. Sly, David M. Tarlinton, Gary P. Anderson, Margaret L. Hibbs

Research output: Contribution to journalArticlepeer-review

76 Citations (Scopus)

Abstract

The etiology of asthma, a chronic inflammatory disorder of the airways, remains obscure, although T cells appear to be central disease mediators. Lyn tyrosine kinase has been implicated as both a facilitator and inhibitor of signaling pathways that play a role in allergic inflammation, although its role in asthma is unclear because Lyn is not expressed in T cells. We show in the present study that Lyn-/- mice develop a severe, persistent inflammatory asthma-like syndrome with lung eosinophilia, mast cell hyperdegranulation, intensified bronchospasm, hyper IgE, and Th2-polarizing dendritic cells. Dendritic cells from Lyn-/- mice have a more immature phenotype, exhibit defective inhibitory signaling pathways, produce less IL-12, and can transfer disease when adoptively transferred into wild-type recipients. Our results show that Lyn regulates the intensity and duration of multiple asthmatic traits and indicate that Lyn is an important negative regulator of Th2 immune responses.

Original languageEnglish
Pages (from-to)1867-1875
Number of pages9
JournalJournal of Immunology
Volume175
Issue number3
DOIs
Publication statusPublished - 1 Aug 2005
Externally publishedYes

Fingerprint

Dive into the research topics of 'Lyn-deficient mice develop severe, persistent asthma: Lyn is a critical negative regulator of Th2 immunity'. Together they form a unique fingerprint.

Cite this